Clinical Therapeutic Conference: dopaminergic/serotonergic actions of phencyclidine as a model for schizophreniform psychosis.
Gabbert
J F
JF
Department of Pharmacy, Idaho State University, Pocatello, ID, USA.
Giannini
A J
AJ
D000328:Adult; D005260:Female; D006213:Hallucinogens / Q000633:toxicity*; D006801:Humans; D008297:Male; D008960:Models, Psychological; D010622:Phencyclidine / Q000633:toxicity*; D011605:Psychoses, Substance-Induced / Q000188:drug therapy*; D017448:Receptors, Dopamine D2 / Q000187:drug effects; D011985:Receptors, Serotonin / Q000187:drug effects; D018967:Risperidone / Q000627:therapeutic use; D012559:Schizophrenia / Q000139:chemically induced* / Q000188:drug therapy
D006213:Hallucinogens; D017448:Receptors, Dopamine D2; D011985:Receptors, Serotonin; D010622:Phencyclidine; D018967:Risperidone